Abiopharma

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146135 Size: 171 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits